Search

Your search keyword '"Bellissant E"' showing total 408 results

Search Constraints

Start Over You searched for: Author "Bellissant E" Remove constraint Author: "Bellissant E"
408 results on '"Bellissant E"'

Search Results

1. Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study

5. Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

6. Overview of literature monitoring practices of clinical trials vigilance units in French institutional sponsors-A study from the REVISE working group

7. Switch from intravenous to subcutaneous infliximab in inflammatory bowel disease: Which consequences from a pharmacokinetic perspective?

8. Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods

9. Therapeutic drug monitoring of ruxolitinib in graft versus host disease in pediatric allogenic hematopoietic stem cell transplant recipients: A multicenter retrospective study

10. An easy, fast and inexpensive multiplex pharmacogenetics assay to simultaneously analyze 17 clinically relevant genetic polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1 and VKORC1 genes

11. Contribution of voriconazole phenotyping to patient management

14. Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study

16. Vigilance of clinical trials: Retrospective analysis of working time and associated costs for a completed study

17. Deciphering pharmacogenetic-whole blood/intracellular pharmacokinetic-pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

18. Redefining therapeutic drug monitoring of tacrolimus in liver transplantation: can we target trough concentrations below 7 ng/ml during the first month?

19. Pharmacokinetic-pharmacodynamic profile in patients treated with ceftaroline: A retrospective study

20. A case report of a therapeutic drug monitoring-guided sofosbuvir-velpatasvir crushed treatment

21. Clinical trials vigilance: Comparison of sponsor and investigator's imputabilities of serious adverse events in a randomized, double-blinded study

22. Results of one year reconciliation activity in Rennes clinical trials vigilance unit

23. Validation of a high-performance liquid chromatography-tandem mass spectrometry method for the quanYtification of beta-lactams in cardiac valves

24. A survey on French hospital physicians' certification to the Good Clinical Practices

29. Assessment of time spent for Clinical trial vigilance activities in an academic Trials Vigilance Unit

30. Pharmacokinetic and pharmacodynamic profile of beta-lactam antibiotics in patients treated for infective endocarditis a five-year retrospective study

31. Beta-lactams and Proton Pump Inhibitors a new example of renal transporters mediated drug-drug interaction

42. Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

43. Cost-effectiveness of full versus targeted monitoring of randomized controlled trials

Catalog

Books, media, physical & digital resources